Acute Viral Hepatitis in the United States–Mexico Border Region: Data from the Border Infectious Disease Surveillance (BIDS) Project, 2000–2009

被引：0

作者：

Philip R. Spradling

Jian Xing

Alba Phippard

Maureen Fonseca-Ford

Sonia Montiel

Norma Luna Guzmán

Roberto Vázquez Campuzano

Gilberto Vaughan

Guo-liang Xia

Jan Drobeniuc

Saleem Kamili

Ricardo Cortés-Alcalá

Stephen H. Waterman

机构：

[1] National Center for HIV,Division of Viral Hepatitis

[2] Hepatitis,Division of Global Migration and Quarantine

[3] STD,undefined

[4] and TB Prevention,undefined

[5] Centers for Disease Control and Prevention,undefined

[6] Centers for Disease Control and Prevention,undefined

[7] General Directorate of Epidemiology,undefined

[8] National Institute for Epidemiologic Diagnosis and Reference,undefined

来源：

Journal of Immigrant and Minority Health | 2013年 / 15卷

关键词：

Acute viral hepatitis; Border; Mexico; Surveillance;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Little is known about the characteristics of acute viral hepatitis cases in the United States (US)–Mexico border region. We analyzed characteristics of acute viral hepatitis cases collected from the Border Infectious Disease Surveillance Project from January 2000–December 2009. Over the study period, 1,437 acute hepatitis A, 311 acute hepatitis B, and 362 acute hepatitis C cases were reported from 5 Mexico and 2 US sites. Mexican hepatitis A cases most frequently reported close personal contact with a known case, whereas, US cases most often reported cross-border travel. Injection drug use was common among Mexican and US acute hepatitis B and C cases. Cross-border travel during the incubation period was common among acute viral hepatitis cases in both countries. Assiduous adherence to vaccination and prevention guidelines in the US is needed and strategic implementation of hepatitis vaccination and prevention programs south of the border should be considered.

引用

页码：390 / 397

页数：7

共 58 条

[1] Doyle T(2000)Infectious disease morbidity in the U.S. region bordering Mexico J Infect Dis 182 1503-573
[2] Bryan R(2008)Mexico’s evolving HIV epidemic J Am Med Assoc 300 571-102
[3] Strathdee SA(2003)The U.S.–Mexico border infectious disease surveillance project: establishing binational border surveillance Emerg Infect Dis 9 97-13
[4] Magis-Rodriguez C(2003)Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus MMWR 52 1-829
[5] Weinberg M(1999)Hepatitis A in Latin America: a changing epidemiologic pattern Am J Trop Med Hyg 61 825-296
[6] Waterman S(2008)Is there a shift in the epidemiology of hepatitis A in Mexican children? Rev Invest Clin 60 292-1022
[7] Lucas CA(2004)Declining hepatitis A seroprevalence: a global review and analysis Epidemiol Infect 132 1005-355
[8] Tapia-Conver R(2009)A low steady HBsAg seroprevalence is associated with a low incidence of HBV-related liver cirrhosis and hepatocellular carcinoma in Mexico: a systematic review Hepatol Int 3 343-290
[9] Santos JI(2008)Prevalence of hepatitis C virus in the Mexican population: a systematic review J Infect 56 281-8
[10] Cavalcanti AM(2007)Low prevalence of anti-hepatitis C virus antibodies in Mexico: a systematic review Intervirology 50 1-e73

← 1 2 3 4 5 6 →